Company intelligence / Profile preview

Diabetech

London, England, United Kingdomdiabetech.net ↗

Ownership: Private
Development stage: Commercial

Overview

Diabetech has developed multiple wireless diabetes monitoring devices, including the GlucoMON® system, and has conducted over 20 research pilots. The company also offers an AI-powered diabetes coaching program ("Dani") that provides personalized support via messaging apps. Their technology focuses on passive data collection to improve patient engagement and outcomes in diabetes management. Peer-reviewed publications have validated their approach, with ongoing efforts to commercialize next-generation devices and expand partnerships with payers and manufacturers.

Therapeutic areas: Endocrinology
Modalities: DeviceSoftwareArtificial intelligence-driven digital health coaching
Industry: Physiological Monitoring

Partnerships

In discussions with major blood sugar monitoring device manufacturers, payers such as Kaiser Permanente, NHS UK, Blue Cross Blue Shield franchisees, State Medicaid programs; large employers like AT&T are also prospects for deployment of their solutions

Beyond the preview

Go deeper on Diabetech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diabetech.

Explore the full profile